Ownership history in Catalys Pacific, LLC · 9 quarters on record
This page tracks every 13F SEC filing in which Catalys Pacific, LLC reported a position in Phathom Pharmaceuticals, Inc. (PHAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,429,014 | +261,900 | +22.4% | 7.63% | $23.7M | $16.59 |
| 2025 Q3 | UNCHANGED | 1,167,114 | — | 0% | 3.91% | $13.7M | $11.77 |
| 2025 Q2 | UNCHANGED | 1,167,114 | — | 0% | 8.50% | $11.2M | $9.59 |
| 2025 Q1 | UNCHANGED | 1,167,114 | — | 0% | 4.92% | $7.3M | $6.27 |
| 2024 Q4 | ADDED | 1,167,114 | +44,542 | +4.0% | 8.18% | $9.5M | $8.12 |
| 2024 Q3 | ADDED | 1,122,572 | +400,610 | +55.5% | 16.19% | $20.3M | $18.08 |
| 2024 Q2 | UNCHANGED | 721,962 | — | 0% | 5.61% | $7.4M | $10.30 |
| 2024 Q1 | UNCHANGED | 721,962 | — | 0% | 5.18% | $7.7M | $10.62 |
| 2023 Q4 | INITIATED | 721,962 | — | — | 6.18% | $6.6M | — |
As of 2025 Q4 — sorted by position size